Ownership history in ROYCE & ASSOCIATES LP · 18 quarters on record
This page tracks every 13F SEC filing in which ROYCE & ASSOCIATES LP reported a position in IRONWOOD PHARMACEUTICALS INC (IRWD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 300,619 | -205,441 | -40.6% | 0.00% | $394K | $1.31 |
| 2025 Q2 | REDUCED | 506,060 | -229,376 | -31.2% | 0.00% | $363K | $0.72 |
| 2025 Q1 | UNCHANGED | 735,436 | — | 0% | 0.01% | $1.1M | $1.47 |
| 2024 Q4 | ADDED | 735,436 | +72,502 | +10.9% | 0.03% | $3.3M | $4.43 |
| 2024 Q3 | ADDED | 662,934 | +64,353 | +10.8% | 0.02% | $2.7M | $4.12 |
| 2024 Q2 | ADDED | 598,581 | +7,577 | +1.3% | 0.04% | $3.9M | $6.52 |
| 2024 Q1 | ADDED | 591,004 | +292,241 | +97.8% | 0.05% | $5.1M | $8.71 |
| 2023 Q4 | ADDED | 298,763 | +14,013 | +4.9% | 0.03% | $3.4M | $11.44 |
| 2023 Q3 | ADDED | 284,750 | +2,130 | +0.8% | 0.03% | $2.7M | $9.63 |
| 2023 Q2 | REDUCED | 282,620 | -1,603,627 | -85.0% | 0.03% | $3.0M | $10.64 |
As of 2025 Q4 — sorted by position size